Detail akcie Agilent Tech online

Business Summary: Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.
Financial Summary: BRIEF: For the nine months ended 31 July 2026, Agilent Technologies Inc revenues increased 8% to $5.51B. Net income increased 16% to $1.01B. Revenues reflect Life Sciences and Diagnostics Markets segment increase of 9% to $2.16B, Agilent CrossLab segment increase of 7% to $2.3B, Applied Markets segment increase of 9% to $1.05B, Europe segment increase of 9% to $1.53B, Asia Pacific segment increase of 7% to $1.77B.